🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II parallel group randomized controlled trial with 294 adol...
Status
Recruiting
Location
UConn Health
Start Date
2024-11-26
Trial ID
NCT06395467
A study to evaluate the effect of over- the- counter (OTC) lubricating eye ...
Status
Recruiting
Location
Andover Eye Associates
Start Date
2026-06-03
Trial ID
NCT07676084
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
The purpose of this study is to evaluate the efficacy of a 14-session behav...
Status
Completed
Location
National Development and Research Institutes, Inc
Start Date
2001-12
Trial ID
NCT00183209
Treatments Being Tested
This is a Phase 1, open-label, single-dose study of the safety, tolerabilit...
Status
Terminated
Location
University Hospital Cologne-Clinical Trial Center
Start Date
2017-05-29
Trial ID
NCT02808052
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of the up-titra...
Status
Completed
Location
SGS Clinical Pharmacology Unit (located in ZNA Stuivenberg)
Start Date
2019-03-20
Trial ID
NCT03882255
Treatments Being Tested
Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-02-15
Trial ID
NCT04737655
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The purpose of this study was to evaluate no less therapeutic efficacy and ...
Status
Completed
Location
Sandoz Investigational Site
Start Date
2017-02-22
Trial ID
NCT03095521
Treatments Being Tested
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433